HB 1809 (2026)
Establish medical psilocybin advisory board
This bill is still active.
Last updated 2026-04-29 6:41 pm
Summary:
Authorizes the medical use of psilocybin for specific conditions and establishes a regulatory program and advisory board within the Department of Health and Human Services.
The House rewrote the bill to solely establish a medical psilocybin advisory board to assess the advantages and
disadvantages of the use of psilocybin for therapeutic purposes.
Status:
Public Hearing Date:
04/08/2026 09:45 am
Public Hearing Location:
SH Room 100
House Voting Date:
03/26/2026
Senate Voting Date:
05/07/2026
The data you see here is pulled daily from official government databases. The bill summary is created by Citizens Count staff. Learn more about our methodology for summarizing and updating bills. Visit the official New Hampshire government website for a deep-dive on this bill.
Browse related articles and bills:
